+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infectious Enteritis Drug"

Global Infectious Enteritis Treatment Market - Product Thumbnail Image

Global Infectious Enteritis Treatment Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
Global Infectious Enteritis Treatment Market 2022-2026 - Product Thumbnail Image

Global Infectious Enteritis Treatment Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Infectious Enteritis is a type of Gastrointestinal Drug used to treat a variety of gastrointestinal infections. It is a broad-spectrum antibiotic that is effective against a wide range of bacteria, including Salmonella, Shigella, and Campylobacter. It is also used to treat traveler's diarrhea, which is caused by bacteria or parasites. Infectious Enteritis is available in both oral and injectable forms. It is usually taken as a single dose or in multiple doses over a period of time. The Infectious Enteritis Drug market is a rapidly growing segment of the Gastrointestinal Drugs market. It is driven by the increasing prevalence of gastrointestinal infections, as well as the growing demand for effective treatments. The market is expected to continue to grow in the coming years, as new treatments are developed and more people become aware of the need for effective treatments. Some of the major companies in the Infectious Enteritis Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more